Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00706537
What this trial is testing

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

Who this might be right for
Non-Alcoholic Steatohepatitis(NASH)
Pfizer 9
Not applicableLooking for participantsNCT06571474
What this trial is testing

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Who this might be right for
ObesityNon-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2+1 more
Bettina Mittendorfer 60
Not applicableStudy completedNCT03995056
What this trial is testing

Exercise Study in Subjects With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseGastrointestinal MicrobiomeExercise
University of Eastern Finland 49
Large-scale testing (Phase 3)Ended earlyNCT00576667
What this trial is testing

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes

Who this might be right for
Fatty Liver
Sanofi 165
Not applicableUnknownNCT06167902
What this trial is testing

The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial

Who this might be right for
Non-alcoholic Fatty Liver Disease
Peking Union Medical College Hospital 200
Not applicableLooking for participantsNCT05477212
What this trial is testing

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

Who this might be right for
Permeability; IncreasedNAFLDObesity
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 30
Large-scale testing (Phase 3)Ended earlyNCT00678587
What this trial is testing

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Who this might be right for
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCV+8 more
GlaxoSmithKline 292
Not applicableStudy completedNCT04186793
What this trial is testing

Comparison of Dietary Sugar Reduction Methods

Who this might be right for
Nonalcoholic Fatty Liver Disease
Emory University 8
Early research (Phase 1)Study completedNCT03597217
What this trial is testing

A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults

Who this might be right for
Healthy
Pfizer 15
Early research (Phase 1)Study completedNCT03809052
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Who this might be right for
Safety and Tolerability
Galecto Biotech AB 78
Early research (Phase 1)Looking for participantsNCT07403604
What this trial is testing

Effect of Insulin Lowering on Lipogenesis

Who this might be right for
HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+2 more
Columbia University 25
Not applicableStudy completedNCT04573543
What this trial is testing

The Role of Immune Semaphorins in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseImmune ResponseBiomarkers+2 more
University Hospital for Infectious Diseases, Croatia 160
Early research (Phase 1)Not Yet RecruitingNCT06558422
What this trial is testing

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Who this might be right for
Insulin ResistanceHyperinsulinemiaMetabolic Dysfunction Associated Steatotic Liver Disease+3 more
Columbia University 36
Not applicableNot Yet RecruitingNCT05813301
What this trial is testing

NAFLD in Patient of Hypothyroidism

Who this might be right for
NAFLD
Assiut University 100
Testing effectiveness (Phase 2)Looking for participantsNCT03884075
What this trial is testing

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Who this might be right for
Non-Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 104
Not applicableStudy completedNCT06499675
What this trial is testing

Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study

Who this might be right for
ObesityObesity, MorbidBariatric Surgery Candidate+2 more
Egyptian Liver Hospital 272
Not applicableNot Yet RecruitingNCT06764056
What this trial is testing

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated-dysfunction Steatohepatitis (MASH)Obesity
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 120
Post-approval studies (Phase 4)Study completedNCT05905185
What this trial is testing

Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity

Who this might be right for
Obesity
National University of Malaysia 29
Post-approval studies (Phase 4)Looking for participantsNCT07272343
What this trial is testing

The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University 100
Very early researchStudy completedNCT05523648
What this trial is testing

Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD

Who this might be right for
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
Sichuan Leshan Traditional Chinese Medicine Hospital 92
Next Page